Fetal and Neonatal Effects of N-Acetylcysteine When Used for Neuroprotection in Maternal Chorioamnionitis.

J Pediatr · 2016 · PMC4698030 · PMID 26545726

Europe PMC DOI

hedged sentence

0.0800

closest p · 1.6× alpha

0.0800

boldest claim

The sentences

a weak trendP = .08so close (0.05 < p ≤ 0.1)

MRS of myoinositol (mI)/N-acetylaspartate (NAA) ratio in the BG showed a weak trend, with control infants having higher mI/NAA ratios than infants treated with NAC, controlling for GA at birth ( P = .08, n = 16).

also in 1,404 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.